However, in 2013 and 2014, Sanofi embarked on much more aggressive increases, nearly doubling the drugs WAC to $248 by the end of 2014. (Staff Report, Insulin: Examining The Factors Driving The Rising Cost Of A Century Old Drug, United States Senate Finance Committee, 1/14/21) Novo Nordisk And Sanofi Not Only Closely Monitored The Others Price Increases, They Actually Increased Prices In LockstepSometimes Within Hours Or Days Of Each OtherA Practice Known As Shadow Pricing. Rather than seeking to undercut its competitors pricing, from 2014 on Novo Nordisk engaged in a cat-and-mouse strategy of pricing that followed Sanofis price increases closely, sometimes mirroring them within days or even hours
Reported concerns may include headache, nausea, injection-site irritation, fatigue, or unpredictable responses depending on product quality and route of administration
For injectable preparations, compounding pharmacies with proper licensing provide quality assurance that grey-market sources cannot
In this stack, AOD-9604 timing typically shifts
That persistent belly bloat, stubborn weight, or sluggish energy isnt just aging. More often than not, its chronic inflammation